These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 6153722)
1. Cholecystokinin (pancreozymin). 5. Hormonally active desamino derivative of Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2. Bodanszky M; Martinez J; Walker M; Gardner JD; Mutt V J Med Chem; 1980 Jan; 23(1):82-5. PubMed ID: 6153722 [No Abstract] [Full Text] [Related]
2. Synthesis and some pharmacological properties of Z-Tyr(SO3H)-Met-Gly-Trp-Met-Asp(Phe-NH2)-OH, a 32-beta-aspartyl analogue of cholecystokinin (pancreozymin) 27-33. Martinez J; Winternitz F; Bodanszky M; Gardner JD; Walker MD; Mutt V J Med Chem; 1982 May; 25(5):589-93. PubMed ID: 6177857 [TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin (pancreozymin). 4. Synthesis and properties of a biologically active analogue of the C-terminal heptapeptide with epsilon-hydroxynorleucine sulfate replacing tyrosine sulfate. Bodanszky M; Martinez J; Priestley GP; Gardner JD; Mutt V J Med Chem; 1978 Oct; 21(10):1030-5. PubMed ID: 722712 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds. Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054 [TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin (pancreozymin). Synthesis and properties of the N alpha-acetyl-derivative of cholecystokinin 27-33. Bodanszky M; Tolle JC; Gardner JD; Walker MD; Mutt V Int J Pept Protein Res; 1980 Nov; 16(5):402-11. PubMed ID: 6163740 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid. Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048 [TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin (pancreozymin). 3. Synthesis and properties of an analogue of the C-terminal heptapeptide with serine sulfate replacing tyrosine sulfate. Bodanszky M; Natarajan S; Hahne W; Gardner JD J Med Chem; 1977 Aug; 20(8):1047-50. PubMed ID: 894673 [TBL] [Abstract][Full Text] [Related]
8. N alpha-carboxyacyl analogues of CCK with a substituted Gly: interaction with pancreatic and gallbladder CCK receptors. von Schrenck T; Müller K; Schulze C; Mirau S; Raedler A; Greten H Peptides; 1993; 14(6):1309-15. PubMed ID: 7510882 [TBL] [Abstract][Full Text] [Related]
9. Investigation of peripheral cholecystokinin receptor heterogeneity by cyclic and related linear analogues of CCK26-33: synthesis and biological properties. Charpentier B; Durieux C; Menant I; Roques BP J Med Chem; 1987 Jun; 30(6):962-8. PubMed ID: 2438407 [TBL] [Abstract][Full Text] [Related]
10. Evidence for cholecystokinin receptor subtype in endocrine pancreas. Verspohl EJ; Hafner B; He X; Knittel JJ Peptides; 1994; 15(8):1353-60. PubMed ID: 7535422 [TBL] [Abstract][Full Text] [Related]
11. Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists. Shiosaki K; Lin CW; Kopecka H; Craig R; Wagenaar FL; Bianchi B; Miller T; Witte D; Nadzan AM J Med Chem; 1990 Nov; 33(11):2950-2. PubMed ID: 1700123 [No Abstract] [Full Text] [Related]
12. Cholecystokinic activity of N alpha-hydroxysulfonyl-[Nle28,31]CCK26-33 analogues modified at the C-terminal residue. Sugg EE; Serra M; Shook JE; Yamamura HI; Burks TF; Korc M; Hruby VJ Int J Pept Protein Res; 1988 Jun; 31(6):514-9. PubMed ID: 2457563 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of [27-Tyr]-cholecystokinin-pancreozymin (CCK-PZ). Yajima H; Mori Y; Kiso Y; Koyama K; Tobe T; Setoyama M; Adachi H; Kanno T; Saito A Chem Pharm Bull (Tokyo); 1976 May; 24(5):1110-3. PubMed ID: 1021264 [No Abstract] [Full Text] [Related]
14. Calcitonin gene-related peptide as modulator of cholecystokinin-induced contraction of guinea pig gall bladder strips in vitro. Kline LW; Pang PK Ann N Y Acad Sci; 1992 Jun; 657():541-2. PubMed ID: 1637119 [No Abstract] [Full Text] [Related]
15. Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin. Rodriguez M; Galas MC; Lignon MF; Mendre C; Laur J; Aumelas A; Martinez J J Med Chem; 1989 Oct; 32(10):2331-9. PubMed ID: 2477546 [TBL] [Abstract][Full Text] [Related]
16. Selective modification of the ability of cholecystokinin to cause residual stimulation of pancreatic enzyme secretion. Villanueva ML; Martinez J; Bodanszky M; Collins SM; Jensen RT; Gardner JD Am J Physiol; 1982 Sep; 243(3):G214-7. PubMed ID: 6180646 [TBL] [Abstract][Full Text] [Related]
17. Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33. Solomon TE; Yamada T; Elashoff J; Wood J; Beglinger C Am J Physiol; 1984 Jul; 247(1 Pt 1):G105-11. PubMed ID: 6204542 [TBL] [Abstract][Full Text] [Related]
18. Suc-Tyr(SE)-Met-Gly-Trp-Met-Asp-beta-phenethylamide(410): a competitive antagonist of cholecystokinin-induced contractions in smooth muscles in vitro. Rakovska A; Henklein P; Milenov K; Nieber K; Oehme P Methods Find Exp Clin Pharmacol; 1987 Jul; 9(7):429-35. PubMed ID: 3683016 [TBL] [Abstract][Full Text] [Related]
19. Syntheses and biological activities of methoxinine-analogues of the C-terminal octapeptide of cholecystokinin-pancreozymin. Gillessen D; Trzeciak A; Müller RK; Studer RO Int J Pept Protein Res; 1979 Feb; 13(2):130-6. PubMed ID: 429089 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of electrically stimulated guinea-pig gallbladder contraction by subthreshold concentrations of gastrointestinal hormones in vitro. Foesel S; Sewing KF Experientia; 1978 Feb; 34(2):205-6. PubMed ID: 624352 [No Abstract] [Full Text] [Related] [Next] [New Search]